SCHEMBL8734182

SCHEMBL8734182

COc1ccc(CNCC(O)C(Cc2ccccc2)NC(=O)N(C)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.56
CTSD P07339 7/20 0.53
BACE1 P56817 14/20 0.53
SLC6A11 P48066 1/20 0.53
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8729411 0.91 BACE1 (0.61) BCHECTSDBACE1SLC6A11
SCHEMBL3351385 0.90 BCHE (0.69) BCHECTSDBACE1CYP3A4
SCHEMBL3351378 0.90 BCHE (0.69) BCHECTSDBACE1CYP3A4
SCHEMBL5450466 0.87 BCHE (0.61) BCHECTSDBACE1SLC6A11
SCHEMBL5450473 0.87 BCHE (0.61) BCHECTSDBACE1SLC6A11
SCHEMBL8731396 0.85 BACE1 (0.54) BCHECTSDBACE1SLC6A11
SCHEMBL8734184 0.84 BCHE (0.58) BCHECTSDBACE1SLC6A11
SCHEMBL8731465 0.82 BACE1 (0.50) BCHECTSDBACE1SLC6A11
SCHEMBL7322817 0.82 BACE1 (0.50) BCHECTSDBACE1SLC6A11
SCHEMBL3354775 0.82 BCHE (0.69) BCHECTSDBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5708004-A ENZYME INHIBITORS FOR TREATMENT OF AIDS MONSANTO COMPANY (US) 1998-01-13 US disclosed
US-5703076-A TREATING HIV, AIDS G. D. SEARLE & CO. (US) 1997-12-30 US disclosed
US-5698569-A Retroviral protease inhibitors G. D. SEARLE & CO. (US) 1997-12-16 US disclosed
US-5510349-A HUMAN IMMUNODEFICIENCY VIRUS G.D. SEARLE & CO. (US) 1996-04-23 US disclosed
US-5510378-A Retroviral protease inhibitors G.D. SEARLE & CO. (US) 1996-04-23 US disclosed
US-5510487-A TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS G.D. SEARLE & CO. (US) 1996-04-23 US disclosed